Global Particle Therapy Market, By Therapy Type (Proton Therapy, Heavy Ion Therapy, Fast-Neutron Therapy), Component Type (Products, Services), System (Multi-Room Systems, Single-Room Systems), Cancer Type (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Other Cancers), Application (Treatment Application, Research Application), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
The particle therapy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 9.45% in the above-mentioned forecast period. Rising advantages offered by particle therapy over photon therapy drives the particle therapy market.
Particle therapy is defined as a form of external beam radiotherapy which uses beams of energetic neutrons, positive ions or protons for cancer treatment. Proton therapy, fast-neutron therapy, carbon–ion radiotherapy among others are some of the various methods of particle therapy.
Growing prevalence of cancer all over the globe is the vital factor escalating the market growth, also rising adoption of particle therapy in clinical trials, rising number of particle therapy centers worldwide, rising occurrences of cancer, increasing investment for cancer research and rising number of particle therapy centers and clinical trials are the major factors among others driving the particle therapy market. Moreover, rising technological advancements and modernization in the healthcare machinery, rising research and development activities in the healthcare sector and rising emerging markets with increasing geriatric population base will further create new opportunities for particle therapy market in the forecasted period of 2021-2028.
However, rising infrastructural challenges in healthcare facilities, increasing affordability and accessibility of treatments and increasing unfavourable reimbursement policies and limited insurance coverage for particle therapy are the major factors among others which will obstruct the market growth, and will further challenge the growth of particle therapy market in the forecast period mentioned above.
The particle therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the particle therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Particle Therapy Market Scope and Market Size
The particle therapy market is segmented on the basis of therapy type, component type, system, cancer type and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of therapy type, the particle therapy market is segmented into proton therapy, heavy ion therapy and fast-neutron therapy.
- Based on component type, the particle therapy market is segmented into products and services. Products have been further segmented into cyclotrons, synchrotrons and synchrocyclotrons.
- Based on system, the particle therapy market is segmented into multi-room systems and single-room systems.
- Based on cancer type, the particle therapy market is segmented into prostate cancer, breast cancer, lung cancer, head and neck cancer and other cancers. Other cancers have been further segmented into lymphoma, sarcoma, spine cancer, pancreatic cancer, brain cancer, secondary/reoccurring cancer, gastrointestinal cancer and others.
- The particle therapy market is also segmented on the basis of application into treatment application and research application.
Particle Therapy Market Country Level Analysis
The particle therapy market is analysed and market size insights and trends are provided by country, therapy type, component type, system, cancer type and application as referenced above.
The countries covered in the particle therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the particle therapy market due to increasing adoption of particle therapy in clinical trials, rising number of particle therapy centers worldwide, rising occurrences of cancer, increasing investment for cancer research and rising number of particle therapy centers and clinical trials in this region. Europe and Asia-Pacific are the expected region in terms of growth in particle therapy market due to rising per capita income, improving healthcare infrastructure, and increasing supportive government activities in countries such as China, Japan, and India
The country section of the particle therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The particle therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for particle therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the particle therapy market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Particle Therapy Market Share Analysis
The particle therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the particle therapy market.
The major players covered in the particle therapy market report are Advanced Oncotherapy, IBA Worldwide, Accuray Incorporated, Brainlab, Elekta AB, Panacea, Shinva Medical Instrument Co. Ltd, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, Optivus Proton Therapy Inc., ProTom International, Provision Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., SAH Global LLC, Mitsubishi Electric Corporation, Koninklijke Philips N.V. and PTW Freiburg GmbH. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.